Immunocytochemical examination of Akt, mTOR, and Pax-2 for endometrial carcinoma through thin-layer endometrial cytology
This investigation probed varying threshold levels pertaining to Akt, mTOR, and Pax-2, consequently assisting in endometrial lesion-type identification. IHC within ECT (endometrial cytology test) analyses for Akt, mTOR, and Pax-2 could enhance the capacity for diagnosing EC/pre-malignant lesions.
Authors
- Ke Ma (ORCID: https://orcid.org/0000-0002-5206-1038)
- Yiting Meng
- Rui Chen (ORCID: https://orcid.org/0000-0002-4281-6564)
- Xi Yang (ORCID: https://orcid.org/0000-0002-9843-3925)
- Qin-ping Liao (ORCID: https://orcid.org/0000-0003-3399-1819)
- Zihui Yang (ORCID: https://orcid.org/0000-0003-1457-5107)
- Jianghui Yang
- Jia Wen
Institutions
- Beijing Tsinghua Chang Gung Hospital (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-04-28
- DOI
- https://doi.org/10.3389/fmed.2025.1576060
- Citations
- 1
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.06
Funders
- Tsinghua University
- Beijing Municipal Administration of Hospitals
- Beijing Talents Fund